All News
Experts at CenExel Clinical Research Sites Tackle COVID-19 Vaccine Testing
Salt Lake City, Sep. 2, 2020 /PRNewswire/ — CenExel Centers of Excellence are participating in U.S. Operation Warp Speed projects to advance COVID-19 vaccine research quickly without sacrificing quality. The Centers are already supporting seven ongoing trials for this...
CenExel’s Research Centers of America Partners with Top Leadership to Fight COVID-19
MIAMI, Jul. 27, 2020 – Dr. Howard Schwartz, Chief Medical Officer and Principal Investigator for vaccine trials at Research Centers of America (RCA), a CenExel Center of Excellence, participated in a roundtable discussion today with U.S. Vice President Mike Pence,...
JBR Clinical Research Surgical Center Earns Prestigious AAAASF Accreditation
Salt Lake City, Jul. 9, 2020 /PRNewswire/ — The JBR Clinical Research surgical center emphasizes its dedication to safety and quality with the receipt of accreditation from the not-for-profit American Association for Accreditation of Ambulatory Surgery Facilities...
Atlanta Center for Medical Research Welcomes New Leadership
ATLANTA, Feb. 5, 2020 /PRNewswire/ — The Atlanta Center for Medical Research (ACMR), a CenExel Center of Excellence, is pleased to announce that Dr. Sarah Kazmi has been promoted to Vice President and General Manager of ACMR, effective February 3, 2020. After 12 years...
CenExel Leads Industry in Psychiatric Studies at Atlanta Center for Medical Research
SALT LAKE CITY, Jan. 14, 2020 /PRNewswire/ — CenExel Clinical Research recently strengthened its psychiatric team with the recruitment of Mark N. Lerman, MD, to serve as a principal investigator for phase I-IV studies at the Atlanta Center for Medical Research (ACMR),...
CenExel Clinical Research Acquires Research Centers of America
SALT LAKE CITY, Dec. 5, 2019 /PRNewswire/ -- CenExel Clinical Research, Inc., ("CenExel") announces the acquisition of Research Centers of America ("RCA") in Hollywood, FL, expanding their Centers of Excellence network to five of the most experienced clinical research...
TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY® Annual Meeting and in International Journal of Nanomedicine
TLC590 showed faster and longer lasting pain relief than ropivacaine SOUTH SAN FRANCISCO, CA and TAIPEI, Taiwan – October 21, 2019 – TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet...
CenExel Chief Scientific Advisor Todd Bertoch, MD, to Lead Session at Pain Therapeutics Summit 2019
SALT LAKE CITY, Sept. 23, 2019 /PRNewswire/ -- CenExel Clinical Research, Inc., ("CenExel" or the "Company") announced that Todd Bertoch, MD, Chief Scientic Advisor for CenExel and Chief Medical Ofcer for JBR Clinical Research, a CenExel Center of Excellence, will...
Todd Bertoch, MD, CenExel Chief Scientific Advisor, To Speak at BTIG Pain Management Forum
SALT LAKE CITY, Sept. 11, 2019 /PRNewswire/ -- CenExel Clinical Research, Inc., ("CenExel" or the "Company") announced that Todd Bertoch, MD, Chief Scientific Advisor for CenExel and Chief Medical Officer for JBR Clinical Research, a CenExel Center of...
CenExel Clinical Research’s Anaheim Clinical Trials Passes FDA, EMA & Japanese PMDA Inspections all Within 45 Days
Webster Capital-based CenExcel Clinical Research Inc. (CenExel) was formed in 2018 with the merger of JBR Clinical Research, a Salt Lake City facility specializing in analgesia research and vaccine testing, with ACMR, an Atlanta-based psychiatric research...
Anaheim Clinical Trials, A CenExel Clinical Research Center of Excellence, Wins Audit “Triple Crown”
SALT LAKE CITY and ANAHEIM, Calif., Sept. 9, 2019 /PRNewswire/ -- CenExel Clinical Research, Inc., ("CenExel" or the "Company") announced that Anaheim Clinical Trials (ACT), an adult and pediatric Phase I through Phase IV clinical research Center of Excellence,...